Cite Filings / ATNM / 0001213900-17-008083
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
424B5

Prospectus

Actinium Pharmaceuticals, Inc. · Filed 2017-07-31 · Acc 0001213900-17-008083

Documents 1

  • 424B5 Prospectus , f424b5072817_actiniumphar.htm

Around this filing

  • 2018-02-01 424B5 Prospectus
  • 2017-08-04 4 Chairman & CEO bought 33,333 shares at $0.75 ($25,000)
  • 2017-08-04 4 Executive Vice President bought 10,000 shares at $0.75 ($7,500)
  • 2017-08-04 SC 13G Amended Statement of Ownership
  • 2017-07-31 424B5 Prospectus
  • 2017-07-28 8-K Material agreement · Regulation FD disclosure
  • 2017-07-27 424B5 Prospectus

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading f424b5072817_actiniumphar.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…